In vivo testing of mucus-permeating nanoparticles for oral insulin delivery using Caenorhabditis elegans as a model under hyperglycemic conditions

  1. Martínez-López, A.L.
  2. González-Navarro, C.J.
  3. Aranaz, P.
  4. Vizmanos, J.L.
  5. Irache, J.M.
Aldizkaria:
Acta Pharmaceutica Sinica B

ISSN: 2211-3843,  2211-3835

Argitalpen urtea: 2021

Alea: 11

Zenbakia: 4

Orrialdeak: 989-1002

Mota: Artikulua

DOI: 10.1016/J.APSB.2021.02.020 GOOGLE SCHOLAR lock_openSarbide irekia editor
Datuen iturria: Scopus